Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
e-ESO Podcasts - A podcast by ESO - European School of Oncology

Categories:
Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil
e-ESO Podcasts - A podcast by ESO - European School of Oncology
Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil